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Abstract
Background
Intimate partner violence (IPV) is an important global public health problem. While there is a
growing literature on the association between IPV and women’s reproductive health (RH)
outcomes, most studies are cross-sectional—which weakens inference about the causal ef-
fect of IPV on women’s RH. This systematic review synthesizes existing evidence from the
strongest study designs to estimate the impact of IPV on women’s use of contraception.
Methods
We searched 11 electronic databases from January of 1980 to 3 December 2013 and re-
viewed reference lists from systematic reviews for studies examining IPV and contraceptive
use. To be able to infer causality, we limited our review to studies that had longitudinal mea-
sures of either IPV or women’s use of contraception.
Results
Of the 1,574 articles identified by the search, we included 179 articles in the full text review
and extracted data from 12 studies that met our inclusion criteria. We limited the meta-
analysis to seven studies that could be classified as subject to low or moderate levels of
bias. Women’s experience of IPV was associated with a significant reduction in the odds of
using contraception (n = 14,866; OR: 0.47; 95% CI: 0.25, 0.85; I2 = 92%; 95% CII
2: 87%,
96%). Restricting to studies that measured the effect of IPV on women’s use of partner de-
pendent contraceptive methods was associated with a reduction in the heterogeneity of the
overall estimate. In the three studies that examined women’s likelihood of using male con-
doms with their partners, experience of IPV was associated with a significant decrease in
condom use (OR: 0.48; 95% CIOR: 0.32, 0.72; I
2 = 51%; 95% CII
2: 0%, 86%).
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Conclusions
IPV is associated with a reduction in women’s use of contraception; women who experience
IPV are less likely to report using condoms with their male partners. Family planning and
HIV prevention programs should consider women’s experiences of IPV.
Introduction
Intimate partner violence (IPV) is both a human rights issue and an important public health
concern. IPV is the most prevalent form of gender-based violence; the 2013 Global Burden of
Disease Study estimates that 30% of women age 15 or over have experienced physical or sexual
IPV [1]. Cross-sectional studies from a number of countries indicate that IPV is associated
with a constellation of women’s reproductive health (RH) outcomes related to contraceptive
use including rapid repeat pregnancy (pregnancy within 24 months of a previous pregnancy)
[2–4]; unintended pregnancy [5–7]; pregnancy termination [7–9]; and incident HIV infection
[9–13].
Reproductive coercion, taking control of women’s RH, is one form of IPV. Women may be
forced to have sex or to practice unprotected sex by their male partners and male partners may
sabotage women’s use of family planning (FP) to increase their female partner’s dependency or
to otherwise express their control over their partner’s decision making [5,6,14–18]. Qualitative
and cross-sectional studies suggest that birth control sabotage is a type of reproductive coer-
cion and that women may adopt contraceptive methods that they can hide from their partners
or that do not require negotiation with their male partners to mitigate this barrier [16,19,20].
Women’s ability to control the timing, spacing, and number of their pregnancies is a critical
health and human rights issue. Addressing the unmet need for FP is a key step to meeting Mil-
lennium Development Goals (MDGs) 3, 4 and 5 which aim to promote gender equity; reduce
maternal and child mortality; and ensure universal access to RH including contraception and
antenatal care, respectively. Understanding how IPV modifies women’s ability to adopt contra-
ception is central to designing FP interventions that allow women who experience IPV to man-
age their fertility and to informing HIV prevention interventions.
Purpose of the Review
In this review we attempt to estimate the causal effect of IPV on contraceptive use. Most of the
existing literature on the association between women’s experience of IPV and contraceptive
use is based on estimates of associations and does not address issues of temporality, which re-
stricts our ability to infer the causal effect of IPV on women’s contraceptive use. This study
builds on recent systematic reviews that have found an association between IPV and different
sexual health outcomes. A 2014 systematic review found an association between IPV and ter-
mination of pregnancy, but included all study designs, including cross-sectional studies [8]. A
2007 systematic review provided an overview of studies that estimated the association between
physical IPV and women’s sexual health outcomes, including contraceptive use and pregnancy
termination, but included all study designs and did not include a meta-analysis of included
studies [21]. To understand the scope of existing evidence for the effect of IPV on women’s use
of contraception, we restrict this systematic review to studies with longitudinal measures of
IPV and/or contraceptive use and to studies that use a case-control design. In keeping with a
Intimate Partner Violence andWomen’s Use of Contraception
PLOS ONE | DOI:10.1371/journal.pone.0118234 February 18, 2015 2 / 25
prior systematic review related to IPV, we define a longitudinal study as one where either the
exposure or the outcome was measured at a minimum of two time points [22].
Methods
Search Strategy
We searched 11 biomedical databases: PubMed (Medline); OvidSP (EMBASE, PsycINFO,
CINAHL); Global Health Library (including LILACS, AFRO, EMRO, PAHO, WHOLIS,
WPRO); and POPLINE from 1 January 1980 to 3 December 2013 to identify research studies
on IPV and women’s RH outcomes. Because of the changes in women’s access to and knowl-
edge of contraceptive methods over time with the introduction of novel contraceptive methods
such as the IUD and oral contraceptives, we restricted our search to 1980 onwards. In addition
to the electronic database searches, we identified citations by reviewing reference lists from rel-
evant reviews and studies. We adapted Medical Subject Headings (MeSH) and text-based
search terms for IPV from prior peer-reviewed literature and systematic reviews of intimate
partner violence [23,24]. An information scientist reviewed the search strategy and pilot tested
the search in Medline, EMBASE and PsycINFO with one of the authors (LM). The PubMed
(Medline) search strategy is provided in S1 Supplementary Text.
Inclusion Criteria
We included studies of women and girls of any age that evaluated the association between re-
spondents’ exposure to IPV by a male partner and an outcome related to women’s RH or to in-
fant health in the initial review of titles and abstracts identified in our search. We included all
types of IPV, whether the abuse was classified as physical, sexual, psychological, or economic.
Because we identified more studies than expected with longitudinal measures of IPV and RH
outcomes, we restricted our inclusion criteria to studies with an outcome related to women’s
use of contraception subsequent to the initial search. We did not restrict our definition of con-
traception and included articles with modern contraceptive methods and traditional methods
of FP. We did not restrict studies by geographic location or language of publication.
Study Designs
While we did not use study design filters in our search, we only considered longitudinal (panel,
cohort, randomized controlled trails (RCTs)) or case-control studies for inclusion in the sys-
tematic review. Where the intervention arm of an RCT intervened on both the exposure to IPV
and outcome of contraceptive use, we used the effect measure from the control arm of the
RCT.
Screening and Data Extraction
We followed the Cochrane guidelines for the systematic review of non-randomized studies and
for the review of randomized studies [25,26], and prepared the manuscript using PRISMA
guidelines (See S1 Supplementary Table for the PRISMA checklist). We registered our system-
atic review protocol with the international prospective register of systematic reviews, PROS-
PERO, (registration number CRD42013006457, S2 Supplementary Text) before initiating our
search. One reviewer (LM) conducted the search; removed duplicate studies; and identified ad-
ditional studies through a review of related articles and systematic reviews. In keeping with the
Cochrane recommendations for the systematic review of non-randomized studies, we assessed
study design features, rather than study design labels, to evaluate whether studies could be clas-
sified as longitudinal or case-control study designs [26]. Two reviewers (LM and DZ)
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independently screened the titles and abstracts of all studies identified through the search strat-
egy to identify studies that met the inclusion criteria for full text review. In cases of disagree-
ment about study inclusion, the study was included in the full text review.
For studies that met our inclusion criteria, but where the study authors did not include a rel-
evant effect measure, we contacted the authors for additional information or for participant-
level data. For studies that included a definition of sexual or physical violence that was not lim-
ited to violence perpetrated by a male intimate partner, we contacted the authors to determine
whether they had measured intimate partner-specific violence. For studies that were in lan-
guages other than English, French, or Spanish, an epidemiologist fluent in the language of the
study worked with LM to determine whether the study was relevant for inclusion. Data were
extracted independently by LM and DZ using a standardized, pre-piloted electronic data ex-
traction form. Discrepancies in data extraction between assessors were resolved
through consensus.
We extracted data on study location; design; sample characteristics and size; type of vio-
lence; interview method and setting; the scale used to measure IPV; IPV-specific interviewer
training; confounders; outcome definitions; and effect measures.
Quality Assessment
We assessed the potential for bias within each study using the Cochrane Methodological Quali-
ty Assessment of Observational Studies for longitudinal and case-control studies (S3 Supple-
mentary Text); the Cochrane Risk of Bias Tool for RCTs (S4 Supplementary Text); and a series
of questions specific to assessing bias in measures of IPV exposure [26]. Two reviewers (LM,
DZ) independently assessed each study’s potential for being affected by the most common
forms of bias in observational studies: selection, confounding, performance, detection, and at-
trition bias. In consultation with other subject matter experts, we created a directed acyclic
graph (DAG) to differentiate between important confounders and variables that are likely on
the causal pathway between IPV and contraceptive use (S6 Fig.). DAGs are used to encode a
priori causal knowledge to identify and distinguish between the variables that are likely to be
common causes of the exposure and outcome (confounders) and the variables that are on the
causal pathway between the exposure and outcome (mediators) [27–29]. Focusing on the as-
sessment of selection and confounding bias and temporal ordering of cause and effect, we clas-
sified studies as having a low, moderate, or high probability of bias. Studies were classified as
having low probability of bias if they were not obviously affected by the aforementioned
sources of bias and if they used methods to reduce the probability of measured confounding in
non-randomized studies such as propensity score matching. Studies classified as subject to
moderate bias adjusted for relevant confounders and had no obvious sources of bias.
Data Analysis
We used random effects meta-analysis to estimate the pooled odds ratio (OR) for the associa-
tion between IPV and women’s use of contraception across studies. We chose random rather
than fixed effects models because we expected a high level of heterogeneity across studies and
standard errors estimated using random effects models are generally more conservative than
those estimated with fixed effects models [30]. All studies reported ORs adjusted for confound-
ing. We used the adjusted OR from each study in the meta-analysis. Where necessary, we in-
verted the adjusted OR presented in the published article so that all effect measures in the
meta-analysis were operating in the same direction (contraceptive use versus non-use). All
analysis were done using Stata version 13.0 (StataCorp LP, College Station Texas). While we
calculated a pooled OR across all studies regardless of study quality, we restricted additional
Intimate Partner Violence andWomen’s Use of Contraception
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meta-analysis to studies that were classified as having a moderate or low probability of bias in
keeping with the Cochrane recommendations for the synthesis of data from observational
studies [26].
We used the I2 statistic to assess heterogeneity of effect estimates across included studies.
The I2 statistic quantifies the proportion of variation across studies due to actual variation rath-
er than chance [31]. Based on the Cochrane Handbook for Systematic Reviews’ recommenda-
tions, we interpreted an I2 statistic between 0% and 40% as representing an insignificant
amount of heterogeneity; 30% to 60% as moderate heterogeneity; and 50% to 90% as substan-
tial heterogeneity; and 75% to 100% as considerable heterogeneity [32]. We estimated the un-
certainty in the heterogeneity estimate using Stata’s heterogi command [33] and used Stata’s
metaninf command to estimate the influence of each individual study on the pooled estimate
[34]. We assessed the degree of probable publication bias by reviewing funnel plots that com-
pare log ORs to their standard errors. We used Egger’s test of funnel plot asymmetry to test the
null hypothesis of no small-study effects.
Ethics Statement
Because the data included in this analysis contain no identifying information and are publically
available, ethical approval was not required for this review.
Results
Overview of Selected Studies
Fig. 1 presents the PRISMA flow diagram of the study selection process. We reviewed the titles
and abstracts of 1,574 articles and included 179 articles in the full text review. Twelve studies
with 17,827 participants met our inclusion criteria (please refer to S2 Supplementary Table for
a list of articles excluded following full text review). We excluded effect estimates from two
RCTs that intervened on the exposure and the outcome in both the control and intervention
arms (n = 385) [35,36]. Table 1 presents a detailed overview of the case-control, the control
arm of the included RCT, and the eight other longitudinal studies included in the systematic re-
view. The intervention and control arms of both the included and excluded RCTs are summa-
rized in S3 Supplementary Table. All of the studies were fairly recent: the earliest publication
date was 2005 and five of the 10 studies were published after 2010. Six of the 10 studies were
conducted in the US [37–42]; two studies were conducted in Central and South America
[43,44]; one study was from India [45]; and the RCT was conducted in Africa [46]. The studies
included a diversity of populations: two studies only included adolescents [40,41] and one
study was limited to methadone clinic patients [37]. Three studies restricted their study popu-
lations to ever-pregnant or ever-delivered women. One study was limited to women who were
pregnant at baseline and had delivered prior to follow-up [43]; and two studies included
women who had given birth within the year prior to their baseline interview [39,41]. Five of
the studies included clinic or hospital-based populations [37,38,41,42,44]; three studies includ-
ed a subset of participants in a population-level longitudinal study [40,43,45]. The size of stud-
ies ranged from 225 to 6,414 (IQR = 337–2,058) subjects. While the median follow-up time
was one year, the time between interviews ranged from three months [44] to five years [45].
Study Quality
Table 2 provides details on the quality of the one case-control and nine longitudinal studies
(n = 17,442) that were included in the meta-analysis. We classified the estimate from the con-
trol arm of the RCT as having a low probability of bias [46]. Five of the other longitudinal
Intimate Partner Violence andWomen’s Use of Contraception
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studies were classified as subject to moderate bias [37–39,43,45]; two longitudinal studies
[40,44] and the case-control study [42] were determined to have a high level of bias.
IPV measurement. Studies varied in their description of IPV and in the time period over
which they assessed IPV. Definitions of intimate partner ranged from “person you most often
had sex with in the last 3 months” [46] to “husband” [45]. Seven of the 10 studies reported
Fig 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0118234.g001
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Table 1. Summary of longitudinal, RCT, and case-control studies that examine the association between IPV and women’s contraceptive use.
Author year Population, country Intimate partner Exposure Comparison Outcome OR (95% CI)
El-Bassel 2005
[37]
337 participants aged 18–55
in a methadone maintenance
program who had a male
intimate partner at 14 clinics;
NYC, US
Sexual or dating
relationship during
past year with
boyfriend, spouse,
regular sex partner,
children’s father
Physical or
sexual IPV in
last 6 months
Neither physical
nor sexual IPV
during the last 6
months
Always vs sometimes/
never use of condoms
in last 6 months
0.41 (0.24, 0.71)
Fantasia 2012
[38]
2000 WRA (mean age 22)
who received RH services at
4 clinics. Excluded women
who reported history of
violence as a child who did
not report current IPV; US
A male partner Physical, sexual,
or emotional IPV
during past year
Never experienced
physical, sexual,
emotional IPV
Not using vs using
contraception in past
yeara
9.7 (6.2, 15.2)
McCarraher2006
[44]
293 women who came to a
clinic for oral contraceptives;
Bolivia
NR Ever experience
of FP-related
physical, or
emotional IPVb
Never experienced
FP-related
physical or
emotional IPV
Discontinuation vs
continuation of oral
contraceptive use in
last 3–6 months
1.91 (1.00, 3.66)
Kacaneck 2013c
[46]
Subset of MIRA trial [76]
participants ages 18–49
recruited from clinics. Limited
to participants who answered
questions on IPV at baseline
and 12 month follow-up;
South Africa, Zimbabwe
Person you most often
had sex with in the
last 3 months
Physical or
sexual IPV in
past yeard
No physical or
sexual IPV in last
year
Sometimes/never vs
always use of
condoms in last 3
months
1.66 (1.39, 1.98)
Salazar 2011 [43] 398 delivered women
(median age 27) who
participated in the Health and
Demographic Surveillance
System; Nicaragua
A male partner Physical, sexual,
or emotional IPV
during year prior
to follow-up
No physical,
sexual, or
emotional IPV
during year prior to
follow-up
Current use vs
nonuse of reversible
contraception 40–47
months after deliverye
2.59 (1.24, 5.40)
Scribano 2013
[39]
6414 delivered women/girls
ages 13–45 who participated
in an in-home intervention for
low-income, ﬁrst-time
mothers; US
Husband, ex-husband,
boyfriend, or ex-
boyfriend
Physical IPV in
year prior to
baseline (one
year after
delivery)
No physical IPV in
year prior to
baseline
Current use vs
nonuse of
contraception one
year after baselinef
0.34 (p = 0.001)g
Stephenson 2013
[45]
4111 rural women/girls ages
15–39 who participated in 2
waves of National Family
Health Survey, restricted to
currently married women
who are not sterilized and not
using contraception at
baseline; India
Husband Physical IPV in
year prior to
baseline
No physical IPV in
year prior to
baseline
Use vs nonuse of
modern contraception
between baseline and
follow-uph
0.73 (0.55, 0.96)
Teitelman 2008
[40]
2058 adolescents aged 11–
26 who participated in Wave
III of the AddHealth Study,
reported at least one male
partner in the past year,
reported previous or currently
sexual activity; US
One of up to three
special romantic
relationships with a
male within the 18
months prior to Wave
III interview
Physical or
emotional IPV in
the year prior to
Wave III
interview
Neither physical
nor emotional IPV
in the year prior to
Wave III interview
Sometimes/never vs
always use of
condoms in year prior
to Wave III interview
1.59 (1.16, 2.18)
Van Horne 2009
[41]
632 adolescents aged 15–19
who gave birth at a hospital
and complete both the 6 and
12 month surveys; US
Current or previous
boyfriend or husband
Physical IPV in
6 months prior
to baseline
No physical IPV in
6 months prior to
baseline
Sometimes vs always
use of condoms one
year after deliveryi
3.82 (1.4, 10.6)
(Continued)
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using a validated scale to measure women’s report of violence. The Conflict Tactics Scale was
used in five studies [37,40,41,43,45]; two studies reported using the Abuse Assessment Screen
[39,42]; one study used the CTS, in addition to the Severity of Violence Against Women Scale
and the Women’s Experience with Battering Scale. Researchers generally classify IPV into four
separate categories: emotional, physical, sexual, and economic. Physical violence was the most
widely measured exposure; all studies included physical violence in their exposure definition;
four studies only measured the effect of physical violence [39,41,42,45]. Different forms of IPV
are not necessarily correlated [1] so studies that limited their classification of IPV to physical
IPV may have underestimated the total effect of IPV. In two studies that included multiple cat-
egorizations of IPV (physical, sexual, and emotional) [42,43], we used the effect estimates from
the most expansive definition to better understand the effect of IPV on women’s use of contra-
ception. In one study with multiple categorizations of IPV, we used the classification that in-
cluded physical and sexual IPV rather than the classification that included physical, sexual,
emotional, and fear of IPV because this was the only study to include fear of IPV as a type of
IPV [46].
Contraceptive use measurement. Five of the 10 studies limited their estimate of the effect
of IPV on women’s contraceptive use to one or two methods, including oral contraceptives
[44], condoms and diaphragms [46], and condoms [37,40,41]. Three of the five studies that in-
cluded a number of different methods considered withdrawal and the rhythm method as
Table 1. (Continued)
Author year Population, country Intimate partner Exposure Comparison Outcome OR (95% CI)
Williams 2008k
[42]
225 hospital-based
participants aged 18–50 who
had a male partner in past
year and who had not had a
tubal ligation or
hysterectomy; US
Married to, living with,
or involved with a
male partner
Physical or
emotional IPV in
year prior to
baseline
No physical or
emotional IPV in
year prior to
baseline
Nonuse vs use of
contraception in year
prior to baselinej
1.8 (0.7, 4.8)
OR, adjusted odds ratio; CI, conﬁdence interval; NYC, New York City; US, United States; IPV, intimate partner violence; WRA, women of reproductive
age; FP, family planning; NR, not reported
aContraception includes: injectables, implants, IUD, male and female sterilization, oral contraceptives, contraceptive patch and ring, barrier methods,
withdrawal and “natural methods.”
bTypes of method-related partner violence include: partner became angry with the woman for using a contraceptive method; the partner threatened the
woman because she was using a method; the partner hit the woman for using a method; and the woman was afraid that her partner would hit her because
she was using a method.
cControl arm of randomized controlled trial.
dWhile the Kacanek study includes a more expansive deﬁnition of IPV that includes physical, sexual, emotional violence and fear of violence; we use the
estimate that includes physical and sexual IPV for comparability given that no other study includes “fear of violence” as a form of IPV.
eReversible contraception excludes sterilization and includes oral contraceptives, IUD, injection, condom, calendar-rhythm method, and withdrawal.
fArticle does not deﬁne which contraceptive methods included; personal communication from author, contraception includes: oral contraceptives, IUD,
injectables, condoms, and spermicide.
gNo CI or standard error reported.
hModern contraception includes: birth control pills, IUD, injection, condom, and male or female sterilization.
iAlso report never versus always use of condoms at follow-up: OR: 3.17 (95% CI: 1.1, 8.9).
jCase-control study.
kContraception includes: injectables; implants; IUD; birth control pills; condom; diaphragm or cervical cap; foam, jelly, or cream; female condom, vaginal
pouch; emergency contraception; “natural family planning” such as the rhythm method, safe period by calendar, safe period by temperature, or cervical
mucus test; withdrawal or pulling-out. Respondents who report female or male sterilization were excluded from the analysis.
doi:10.1371/journal.pone.0118234.t001
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Table 2. Quality assessment of included case-control, RCT, and longitudinal studies.
Author
year
Selection bias Confounding
bias
Temporality Performance
bias
Detection
bias
Attrition bias Overall
likelihood
of bias
Qualitative
assessment
El-Bassel
2005 [37]
Moderate (75%
of those
screened
participated.
Those sampled
and enrolled
possibly different
from those
sampled and not
enrolled in ways
related to the
outcome)
Low; adjusted for:
demographic
factors; prior non-
partner abuse;
mental health;
incarceration; drug
use; relationship
dependenciesa;
baseline condom
use. Uses
matching
Low Low (in person
interview, used
CTS2)
Low (usage
in last 6
months)
Low (MI;
sensitivity
analysis
indicates
informative
censoring
unlikely)
Moderate Special population
limits
generalizability;
adjustment for
factors on causal
pathway (social
support,
depression,
PTSD) may bias
effect estimate
towards the null
Fantasia
2012 [38]
Low
(retrospective
chart review)
Moderate;
adjusted for:
demographic
factors; STIs
Low Moderate
(interview part
of routine
medical care)
Low
(current
usage at
follow-up)
Low
(retrospective
chart review)
Moderate Deﬁnition of
contraception
includes non-
modern methods;
could have
adjusted for
income to control
for access to
contraceptive
methods
Kacanekb
2013 [46]
Moderate (clinic
based
population;
restrict to
participants who
answered IPV-
related questions
at baseline and
12-month follow-
up)
Low; adjusted for
confounders that
were not balanced
after
randomization;
program site;
partner absence;
partner HIV
status; partner
drug use
Low Low (audio-
computer
assisted
interview)
Low (usage
in last 3
months)
Low (sample
restricted to
those who
complete both
interviews)
Low Control arm of
RCT; authors
followed
randomization
procedures;
restricting to
women who
completed both
baseline and
follow-up
interviews may
introduce
selection bias if
IPV is related to
contraceptive use
and women who
experience IPV
are more likely to
drop out of the
study
McCarrah-
er 2006
[44]
Moderate
(excluded
transient women,
may have missed
most vulnerable
women)
High; adjusted for;
partner education,
experience of side
effects of birth
control pills
High
(concurrent
exposure
and outcome
measures)
High (in person
interview,
limited
exposure
deﬁnition to
contraceptive
method related
violence)
Low
(current
usage at
follow-up)
High (53% of
those selected
from clinic
records not
reached for
follow-up)
High Restricting
deﬁnition to
method-related
IPV limits
inference; no
adjustment for
demographic
factors
Salazar
2011 [43]
Low (women
were randomly
selected from a
Demographic
Surveillance
System)
Moderate;
adjusted for:
maternal age,
education;
household SES,
urban/rural
location; parity
Low Low (in-person
interview, used
CTS)
Low
(current
usage at
follow-up)
Low (sensitivity
analysis
indicates
informative
censoring
unlikely)
Moderate Deﬁnition of
contraception
includes non-
modern methods
(Continued)
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Table 2. (Continued)
Author
year
Selection bias Confounding
bias
Temporality Performance
bias
Detection
bias
Attrition bias Overall
likelihood
of bias
Qualitative
assessment
Scribano
2013 [39]
Low (includes all
eligible clients
enrolled in Nurse
Family
Partnership
Program)
Moderate;
adjusted for:
confounder
categories:
demographic and
IPV-related
confounders (no
description of
actual
confounders)
Low Low (in person
report to RN;
use AAS)
Low
(current
usage at
follow-up)
NR Moderate Study uses data
from an intensive
home visiting
program that
could have
affected exposure
and outcome
Stephens-
on 2013
[45]
Moderate
(restricted to
rural, married
women not using
contraceptives at
baseline; if
exposure
associated with
contraceptive
use, may have
selected a higher
proportion of
exposed
individuals who
had outcome)
Moderate;
adjusted for:
maternal age,
education;
household SES;
partner education;
parity; state;
spousal age
difference; fertility
intentions.
Low Low (in person
interview; IPV
measure based
on CTS2 used
for DHS IPV
measures)
Low
(current
usage at
follow-up)
Low (sensitivity
analysis
indicates
informative
censoring
unlikely)
Moderate 3–5 years
between
measures
complicates
inference;
restricting to
contraceptive
nonusers at
baseline may
introduce
selection bias if
IPV affects
contraceptive use;
adjustment for
factor on causal
pathway (parity)
may bias effect
estimate towards
the null
Teitelman
2008 [40]
Low (includes all
adolescents who
report having a
male intimate
partner)
Moderate;
adjusted for:
maternal age,
minority group (no
adjustment for
access to
contraception)
High
(concurrent
exposure
and outcome
measures)
Low (in person
interview; used
CTS)
Moderate
(IPV status
measured
at same
time as
outcome)
Low (sensitivity
analysis
indicates
informative
censoring
unlikely)
High Did not report the
temporally
ordered effect
estimate (instead
measures IPV
and contraceptive
use at Wave III)
Van Horne
2009 [41]
Moderate
(restricted to
those who
completed
baseline and
follow-up; those
retained had
higher
depression levels
and lower self-
esteem than non-
retained)
Moderate;
adjusted for:
minority group,
church
attendance, health
system
monitoring,
partner refusing
condom use,
condom use at 6
months,
pregnancy intent
Low Low (mail
survey;
modiﬁed AAS)
Low (use in
last 6
months)
Low (sample
restricted to
those who
complete both
interviews)
Moderate Potential selection
bias; adjustment
for factor on
causal pathway
(partner refusal to
wear condoms)
likely biases effect
estimate towards
the null
(Continued)
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contraceptive methods [38,42,43], while the remaining two studies limited their definition to
modern methods of contraception. Women were asked to recall their contraceptive use during
the last year [38,40,42], last six months [37,41] or to report current use [39,43]. Effect estimates
included comparisons between use and non-use in seven studies [38,39,42–46], and always and
sometimes or never use in three studies [37,40,41]. The three studies that included women who
had given birth measured women’s use of contraception one [41], two [39], and four [43] years
after delivery, when women are unlikely to continue to use lactational amenorrhea for FP [47].
We inverted the ORs from six of the studies in Table 1 [38,40–42,44,46] to facilitate the com-
parison of outcome measures (e.g., contraceptive use versus non-use) across studies.
Confounder adjustment. All studies reported effect measures that were adjusted for basic
demographic confounders including maternal age, socioeconomic status, and minority status.
Studies also adjusted for prior experience of non-partner abuse [37]; mental health [37]; fertili-
ty intentions [41,45]; and relationship status [42], amongst other potential confounders. Some
studies adjusted for factors thought to mediate the relationship between IPV and contraceptive
use including parity [45], partner refusal to wear condoms [41], social support, and depression
[37].
Additional outcomes. Four studies provided effect estimates for additional RH outcomes,
including: the likelihood of using a hidden method of contraception [38,44]; the odds of using
emergency contraception [38]; reporting multiple sex partners [40]; shortened interpartum in-
tervals [39] and the likelihood of engaging in unprotected anal sex [37]. We only extracted data
on measures of contraceptive use to allow for a comparison across studies.
Meta-analysis
This review aims to evaluate and synthesize existing evidence for the effect of IPV on women’s
use of contraception. As described a priori in our research protocol, we restricted our overall
meta-analysis to studies that were classified as having low or moderate levels of bias and only
Table 2. (Continued)
Author
year
Selection bias Confounding
bias
Temporality Performance
bias
Detection
bias
Attrition bias Overall
likelihood
of bias
Qualitative
assessment
Williamsc
2008 [42]
High (distraught
women not
screened; 62% of
those
approached
didn’t participate;
different
selection method
for cases and
controls)
High; adjusted for:
maternal age,
relationship status
(does not adjust
for factors that
could inﬂuence
access to
contraception
(SES))
NA High (women
complete
survey
regardless of
partner
presence; used
CTS2, SVAWS,
WEB)
Low (use in
last 6
months)
NR High Deﬁnition of
contraception
includes non-
modern methods;
probable
selection,
confounding, and
performance bias
CTS2, modiﬁed Conﬂict Tactics Scale; MI, multiple imputation; PTSD, post-traumatic stress disorder; STI, sexually transmitted infection; IPV, intimate
partner violence; CTS, Conﬂict Tactics Scale; HIV, human immunodeﬁciency virus; SES, socio economic status; RN, registered nurse; AAS, Abuse
Assessment Screen; NR, not reported; DHS, Demographic and Health Surveys; NA, not applicable; SVAWS, Severity of Violence Against Women Scale;
WEB, Women’s Experience with Battering Scale.
aRelationship dependencies include: ﬁnancial dependencies (housing dependency contribution to the household) and drug dependency (partner paid for
the woman’s drugs), whether a partner had ever become angry with them, threatened them, hit them, or if they feared their partner would hit them
because they were using a contraceptive method.
bControl arm of randomized controlled trial.
cCase-control study.
doi:10.1371/journal.pone.0118234.t002
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included the three studies that were classified as having a high level of bias in the subgroup
analysis of the association between the level of bias and the estimated pooled OR.
Subgroup Analysis
As indicated both in the forest plot of the seven studies classified having low or moderate levels
of bias (Fig. 2) and in the forest plot that includes all 10 studies irrespective of bias (S1 Fig.),
there is considerable heterogeneity in effect measures across studies. We performed a series of
subgroup analysis to explore potential sources of heterogeneity. We planned to conduct sub-
group analysis on study quality, type of IPV, and whether studies were limited to pregnant ver-
sus non-pregnant participants a priori. We included a subgroup analysis comparing studies
with non-modern forms of FP and modern contraception post hoc after identifying several
studies that included natural methods of FP, like the rhythm method and withdrawal, rather
than restricting to modern contraceptive methods.
Methodological quality. In Fig. 3, we show the changes in the effect estimates by level of
probable bias. Of the 10 included studies (n = 17,442), three studies were classified as having a
high probability of bias; six studies were found to have a moderate level of bias; and one study,
the control arm of the included RCT, was classified as having a low probability of bias. Group-
ing studies according to their probable bias did not explain a significant amount of the hetero-
geneity in the overall estimate (I2 = 89%, 95% CII
2: 81%, 93%). Both studies classified as having
a high probability of bias and studies classified as subject to low or moderate levels of bias indi-
cated that IPV was associated with a decrease in women’s odds of using contraception (ORhigh
bias: 0.60; 95% CIOR: 0.46, 0.79; I
2 = 0%, 95% CII
2: 0%, 90%; ORmoderate: 0.44; 95% CIOR: 0.18,
1.09; I2moderate = 93%, 95% CII
2: 88%, 96%; and ORlow: 0.60; 95% CIOR: 0.50, 0.72 respectively).
Fig 2. Meta-analysis of the association between IPV and contraceptive use. Estimated effect measures from the Fantasia, Kacanek, and Van Horne
studies have been inverted to present estimates of contraceptive use rather than non-use.
doi:10.1371/journal.pone.0118234.g002
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While we extracted data from two longitudinal studies where the exposure was not clearly mea-
sured before the outcome and the case-control study which had different selection procedures
for cases and controls (selection bias), we classified these studies as having a high probability of
bias and excluded them from subsequent subgroup and meta-analysis.
Classification of contraceptive methods. In Fig. 4, we compare the pooled effect measures
by whether studies included withdrawal and the rhythm method in their classification of con-
traceptive methods or restricted their definition to modern contraceptive methods (e.g., inject-
ables, oral contraceptives, IUD, condoms, bilateral tubal ligation). As mentioned previously,
we only included effect estimates from the seven studies classified as having a low or moderate
probability of bias (n = 14,866). The three studies whose definition of contraception ranged
from modern contraception to less effective forms of FP such as withdrawal and the rhythm
method [38,42,43], were more likely to find a non-significant association between IPV and
women’s use of contraception (n = 6,509; OR: 0.57; 95% CIOR: 0.12, 2.78; I
2 = 97%, 95% CII
2:
95%, 99%) than the four studies that estimated the effect of IPV on women’s use of modern
contraceptive methods (n = 8,357; OR: 0.48; 95% CIOR: 0.34, 0.69; I
2 = 35%, 95% CII
2: 0%,
77%). Excluding estimates from studies that included the rhythm method and “natural family
planning methods” and limiting inference to the effect of IPV on women’s use modern con-
traceptive methods reduced the heterogeneity in the pooled estimate from 97% to 35%. The
high level of heterogeneity in the pooled estimate from studies that included natural FP meth-
ods remained after removing the Salazar study (I2 = 98%). The difference in heterogeneity
Fig 3. Meta-analysis of the association between IPV and contraceptive use, by level of bias. Estimated effect measures from the Fantasia,
McCarraher, Kacanek, Teitelman, Van Horne, andWilliams studies have been inverted to present estimates of contraceptive use rather than non-use.
doi:10.1371/journal.pone.0118234.g003
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when comparing studies whose definition of contraception includes withdrawal and the
rhythm method to studies that limit inference to modern methods may indicate that the broad
definition of contraception in these studies is a source of heterogeneity in the overall meta-
analysis. In the three studies that measured women’s reports of their male partner’s condom
use, (S1 Fig.) women who experienced IPV were significantly less likely to report that their
partners used condoms than women who did not experience IPV (n = 1,943; OR: 0.48; 95%
CIOR: 0.32, 0.72; I
2 = 51%, 95% CII
2: 0%, 86%).
Type of IPV. We used the estimated effect of physical IPV from the two studies that includ-
ed multiple classifications of IPV [43,46] in a meta-analysis of the five studies that measured
exposure to physical IPV, presented in S2 Fig. Physical IPV was significantly associated with a
reduction in women’s use of contraception in four of the five studies, although the pooled OR
was not statistically significant and was subject to a high degree of heterogeneity (n = 12,529;
OR: 0.71; 95% CIOR: 0.45, 1.12; I
2 = 79%, 95% CII
2: 50%, 91%). Because there were only two
studies that specifically explored the effect of sexual or emotional IPV on women’s use of con-
traception [43,46], we could not perform separate meta-analysis of these exposures.
Study population. In S3 Fig., we compare the pooled effect measures between studies that
did and did not restrict to women who had given birth. The pooled effect measure for the three
studies that restricted to delivered women was not significantly different from that of the four
studies that did not restrict to delivered women and did not did not help to explain the hetero-
geneity in the overall estimate (ORrestricted to delivered women: 0.64; 95% CIOR: 0.13, 3.25; I
2 = 87%,
Fig 4. Meta-analysis of the association between IPV and contraceptive use, by definition of FP. Estimated effect measures from the Fantasia,
Kacanek, and Van Horne studies have been inverted to present estimates of contraceptive use rather than non-use.
doi:10.1371/journal.pone.0118234.g004
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95% CII
2: 64%, 96%; ORnot restricted to delivered women: 0.38; 95% CIOR: 0.19, 0.76; I
2 = 94%, 95%
CII
2: 90%, 97%).
Overview of Data Synthesis
The results of the meta-analysis, wherein we pooled the ORs from the 10 studies included in
the meta-analysis irrespective of study quality, indicated that women who experience IPV have
a lower odds of adopting contraception than women who do not experience IPV, although the
results were subject to a high level of heterogeneity (n = 17,442; OR: 0.50; 95% CIOR: 0.32, 0.76;
I2 = 89%, ORI
2: 81%, 93%). When we restricted our inference to the seven studies classified as
subject to low or moderate bias, the odds of women who had experienced IPV reporting con-
traceptive use were 53% lower than the odds for women who had not experienced IPV (n =
14,866; 95% CIOR: 0.25, 0.85; I
2 = 92%, 95% CII
2: 87%, 96%). While no single study was found
to unduly influence the pooled OR, not all of the effect estimates operated in the same direc-
tion. In six of the seven studies included in the pooled meta-analysis, where we restricted to
studies classified as subject to moderate or low bias, women who experienced IPV had a lower
odds of reporting contraceptive use than women who did not. The Salazar study [43], which
examined the effect of physical, sexual, and emotional IPV on the use of a contraceptive meth-
od other than sterilization was a notable exception: the odds of women who experienced IPV
using contraception were 2.59 times the odds of women who did not experience IPV at either
baseline or follow-up (95% CI: 1.24, 5.40). The difference between the effect estimates in the Sa-
lazar study and in the other six studies may be caused by country-level differences in access to
contraception and norms surrounding contraceptive use. The Nicaraguan government works
to ensure open access to contraception through FP programs in the public and private health
sector and uses community-based distribution of contraception to reach underserved commu-
nities [48,49]. Nicaragua’s prevalence of contraceptive use, estimated at 73% in 2013, is well
above the global average for contraceptive use of 63% [50]. While exclusion of the Salazar
study from the pooled estimate did decrease the point estimate and increase the precision of
the pooled OR, removal of the Salazar study did not lead to a decrease the degree of heteroge-
neity in the pooled estimate of studies with low and moderate bias (ORwithout Salazar: 0.36; 95%
CIOR: 0.20, 0.65; I
2 = 92%, 95% CII
2: 85%, 96%).
Analysis of Violence Severity
There are different ways of conceptualizing the severity of violence. Some classifications use
the type of violence; others examine the frequency of violent acts. Three of the longitudinal
studies in this review conceptualized violence severity using the duration of reported violence
[38,43,46]. For studies that included several measures of violence duration, we used the mea-
sure that most closely matched the duration of violence reported in other studies in the vio-
lence severity meta-analysis. In Table 3, we report the effect estimates for the three studies that
included measures of the duration of violence. Categorizing violence as either moderate or se-
vere by using the type of violence has been used previously to predict the severity of adverse
health outcomes [51,52]. Using the classification of violence severity from the Kacanek article
[46], these three studies’ classification of each participant’s experience of IPV as persistent,
measured at both time points; incident, only measured at the most recent time; or remitting,
not measured at the most recent time, but measured previously, provide an opportunity to ex-
plore how the duration of IPV can differentially affect contraceptive use. Fig. 5 presents a forest
plot of these duration measures.
In contrast to the estimated effect of IPV on women’s use of contraception in the other two
studies, the estimates from the Salazar study [43] indicate that women who experience IPV are
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more likely to adopt contraception than women who do not. Across all three studies that in-
clude measures of IPV duration, the magnitude of the effect of IPV on women’s use (or non-
use) of contraception is greatest for women who experience persistent IPV.
Discussion
Summary of Main Findings
Results of the meta-analysis suggest that IPV affects women’s use of contraception. Author’s
classification of contraceptive methods was a potential source of heterogeneity. There is some
evidence for a dose-response relationship between duration of IPV exposure and women’s con-
traceptive use. IPV is associated with a decrease in women’s use of partner dependent methods;
women who experienced IPV were less likely to report that their male partners used condoms
than women who did not. The association between IPV and contraceptive use is likely modi-
fied by contextual factors. In Nicaragua, for example, open access to contraceptive methods
and the wide cultural acceptability of contraception may mean that women who experience
IPV are more likely to use contraception than women who do not in the Nicaraguan context.
Limitations of Included Studies
While the objective of this review was to identify and synthesize the best available estimates of
the effect of IPV on women’s use of contraception, the studies that we identified were subject
to a number of limitations that could have biased our assessment of the relationship between
IPV and women’s use of contraception.
Table 3. Association between the duration of intimate partner violence and women’s contraceptive use as compared to women who have no
history of intimate partner violence.
Author
year
Study type Persistent Incident Remitting Comparison
group
Outcome
measure
Deﬁnition OR (95% CI) Deﬁnition OR (95% CI) Deﬁnition OR (95% CI)
Fantasia
2012a
[38]
retrospective
cohort
Past year
IPV and
IPV during
the past 5
years
9.8 (5.3, 18.3) Past year
IPV only
9.7 (6.2, 15.2) No past year
IPV but a
history of
IPV
4.9 (3.5, 7.0) Never having
experienced
physical,
sexual, or
emotional IPV
Not using
contraceptionb
Salazar
2011 [43]
panel Past year
IPV and
IPV during
last
pregnancy
2.50 (1.04, 5.99) Past year
IPV, no IPV
during last
pregnancy
2.65 (0.53, 13.2) IPV during
last
pregnancy,
no IPV in
past year
0.95 (0.44, 2.04) No IPV during
last
pregnancy, no
IPV in year
prior to
interview
Current use of
contraception
Kacanek
2013 [46]
RCT Physical or
sexual IPV
present at
baseline
and at
follow-up
2.4 (1.25, 4.50) Physical or
sexual IPV
not present
at baseline,
is present
at follow-up
1.48 (0.91, 2.40) Physical or
sexual IPV
present at
baseline, not
present at
follow-up
1.53 (1.04, 2.30) No physical or
sexual IPV at
baseline or at
follow-up
Sometimes/
never vs
always use of
condoms in
last 3 months
OR, adjusted odds ratio; CI, conﬁdence interval; RCT, randomized controlled trial.
aIncludes an additional measure of IPV duration, excluded here for comparability: past year IPV and IPV extending for greater than 5 years, OR: 7.7 (95%
CI: 3.3, 17.6).
bContraception includes: injectables, implants, IUD, male and female sterilization, oral contraceptives, contraceptive patch and ring, barrier methods,
withdrawal and “natural methods.”
doi:10.1371/journal.pone.0118234.t003
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Misclassification of the exposure. Three of the studies limited their definition of IPV to
physical violence. Exposure to different forms of IPV is not necessarily correlated [1]; limiting
the definition of IPV may underestimate the total effect of IPV which would bias effect esti-
mates towards the null value if IPV affect contraceptive use. As expected, the magnitude of ef-
fect estimates from studies that included multiple forms of IPV was greater than the magnitude
of effect estimates from studies that only measured one form of IPV. The range in the defini-
tion of intimate partners across studies may have led to underreporting of violence in studies
that did not consider previous partners or sexual partners as intimate partners. This misclassifi-
cation could have also biased results towards the null value.
All exposure and outcome measures were based on self-reports. Under-reporting of IPV is
both difficult to evaluate and a pervasive issue in IPV-related research [53]. Women who report
IPV may experience an increase in IPV incidence or severity [54–56]. Women may be unlikely
both because of the fear of increased violence and because of the stigma associated with report-
ing [54,57]. Studies that do not interview participants alone or that use interviewers who have
not been trained in interviewing survivors of IPV likely lead to higher levels of under-reporting
of the exposure than studies that follow the WHO best practices for interviewing women about
IPV [9]. No included studies described their interviewer training practices.
Misclassification of the outcome. Three of the 10 studies included in the systematic review
used expansive definitions of contraception that included withdrawal, “natural methods,” and/
Fig 5. Meta-analysis of the association between IPV and contraceptive use, by duration of exposure. Estimated effect measures from the Fantasia
and Kacanek studies have been inverted to present estimates of contraceptive use rather than non-use.
doi:10.1371/journal.pone.0118234.g005
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or the rhythm method [38,42,43]. Women who report using withdrawal or the rhythm method
may not experience the same barriers to access and complicated negotiations with their part-
ners and family members faced by women who try to use modern contraceptive methods. The
classification of women who are not using a modern method of contraception as using contra-
ception could have biased the association between IPV and women’s adoption of contraception
towards the null value in these three studies.
Potential selection bias. Studies that restrict inference to participants who are retained in
each survey wave may introduce selection bias if participants who are retained differ from
those who are not in ways that are related to the exposure and to the outcome of interest [58].
In one study that restricted to participants who were retained in both survey waves, researchers
found that retained participants had lower levels of self-efficacy and higher levels of depression
than those who were not retained [41]. The three studies that restricted their populations to
women who had given birth [39,41,43] may have introduced selection bias by selecting a lower
percentage of women who experience IPV than that of the target population given that women
who experience IPV may be more likely to terminate their pregnancies than women who do
not [8].
Strengths and Limitations of This Review
This is the first systematic review to provide a quantitative estimate of the relationship between
IPV and contraceptive use. We did not restrict our review by language and included a diversity
of databases. Two researchers independently screened all articles and extracted data from re-
search studies included in the systematic review. For studies that included a measure of gender
based violence that was not limited to IPV, we contacted authors to see if they could provide us
with an effect estimate limited to IPV.
In addition to the aforementioned limitations of individual studies that may underestimate
the association between IPV and contraceptive use, there are several limitations to this analysis.
All of the studies included in the systematic review estimate the odds of contraceptive uptake.
Odds ratios estimated using logistic regression generally overestimate relative risks for preva-
lent outcomes [59], like contraceptive use, so the pooled ORs likely overestimate the magnitude
of the relative probability of using contraception when comparing women who do and do not
experience IPV. Because the pooled estimates include studies with different measures of IPV
and the type and duration of contraceptive use, the pooled estimates are meant to provide an
approximate estimate of the average association between IPV and contraceptive use and should
be interpreted with caution.
Although contraceptive method type seemed to account for some heterogeneity in the over-
all estimate, statistical heterogeneity is not necessarily reflective of clinically important hetero-
geneity [60]. While the test for heterogeneity of the OR of included studies was not significant
when restricting to studies that restricted inference to modern contraception, the statistical test
for heterogeneity is underpowered and may not distinguish between actual and chance hetero-
geneity [60,61]. Given the limited number of studies included in the meta-analysis, we were
not able to use meta-regression to explore sources of heterogeneity in the overall estimate
[32,62,63].
Because researchers are unlikely to publish research protocols for observational studies, the
results presented here are likely subject to publication bias. The heterogeneity of our exposure
and outcome and the small number of included studies necessarily complicates the assessment
of publication bias [60]. We assessed the degree of probable publication bias visually by using a
funnel plot to compare study log ORs with their standard errors for all 10 studies included in
the overall meta-analysis (S4 Fig.) and for the seven studies classified as having a low or
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moderate probability of bias (S5 Fig.). With few studies it is difficult to assess potential publica-
tion bias, but both contour funnel plots used to evaluate publication bias are missing studies
from the area of non-significance, which suggests the possibility of some publication bias. Simi-
larly, Egger’s test of funnel plot asymmetry indicated that we could not reject the null hypothe-
sis of no small-study effects when considering all 10 studies (p = 0.764) or when limiting
inference to the seven studies classified as having a low or moderate probability of bias
(p = 0.640) [64].
Causal Inference
Temporality, consistency, strength of association, biological plausibility, and dose-response are
necessary components of the classical approach to causal inference [65] and are used to evalu-
ate the strength of evidence from meta-analysis of observational studies [66]. In all studies in-
cluded in the meta-analysis, the measurement of the exposure proceeded the outcome. The
estimates of the effect of IPV on women’s use of contraception are relatively strong and consis-
tent across a diversity of populations in four countries, with the exception of the estimate from
the Nicaraguan study as noted previously. A prior systematic review provides a comprehensive
overview of the direct and indirect pathways through which IPV may affect women’s con-
traceptive use [21]. Pre-existing research in a number of countries suggests that women change
their contraceptive behavior in the face of IPV and that IPV affects women’s ability to negotiate
condom use with their male partners [5,15,19,67,68]. The meta-analysis of the three studies
that examined violence severity suggests a dose-response relationship between women’s expo-
sure to IPV and their use of contraception. The results from this review suggest that IPV may
have a causal effect on women’s use of contraception and may affect women’s use of male con-
doms with their partners. The suggestion that IPV may have a causal effect on women’s use of
contraception must be evaluated with the understanding that this is a meta-analysis of effect es-
timates from observational studies. While we limited the meta-analysis to studies classified as
having a low or moderate probability of bias, the findings of our meta-analysis are subject to
the residual confounding that likely affects effect estimates from included studies [69]. In the
absence of individual patient level data, as would be used in an individual patient data meta-
analysis, we cannot be sure that the decrease in contraceptive use across studies is caused by
women’s experience of IPV and not by miss-measured or unmeasured confounders.
Implications for Future Research
The purpose of this review was to summarize existing evidence from longitudinal and case-
control studies for the effect of IPV on women’s use of contraception. Of the nine studies that
included longitudinal measures, two studies could not be used to estimate the effect of IPV on
women’s use of contraception because the exposure and the outcome were measured contem-
poraneously. There is a clear need for additional research where the temporal ordering of expo-
sure and outcome allow for a better understanding of the causal effect of IPV on women’s use
of contraception.
Two of the seven studies included in the meta-analysis only assessed the effect of physical vi-
olence on women’s use of contraception. Future research should include a more complete defi-
nition of IPV to better estimate the total impact of IPV on women’s use of contraception.
Sexual and physical IPV may have differential effects on women’s use of contraception; addi-
tional research should consider including estimates of the association between different forms
of IPV and contraceptive use. Reproductive coercion may affect women’s contraceptive use in
the absence of other forms of IPV. Future research could explore additional causal pathways
through which reproductive coercion, community norms about violence, gender inequality,
Intimate Partner Violence andWomen’s Use of Contraception
PLOS ONE | DOI:10.1371/journal.pone.0118234 February 18, 2015 19 / 25
and the influence of in-laws interact with other forms of IPV to affect women’s
contraceptive use.
This review indicates that women who experience IPV are less likely to report that their
male partners use condoms than women who do not. Future research might examine the im-
pact of harm reduction strategies on the ability of women who experience IPV to use condoms
with their male partners. Condom use requires a complex set of negotiations between a woman
and her male partner. Prior research indicates that women who experience IPV may be more
likely to adopt contraceptive methods that they can hide from their partners [14,70,71]. Further
research is needed to understand whether women who experience IPV prefer to adopt long-
acting reversible and permanent contraceptive methods that are less likely to require their part-
ner’s involvement. In meta-analysis, sources of heterogeneity may indicate important sources
of bias [72]. This review suggests that contraceptive method type should be considered as a
source of bias in estimates of the effect of IPV on women’s contraceptive use. To best under-
stand how IPV modifies women’s adoption of contraception or the type of method that
women choose to adopt, future research should consider limiting inference to modern methods
of contraception and might differentiate between methods that do and do not require ongoing
negotiations between a woman and her male partner.
Across studies that included a classification of IPV duration, the magnitude of the effect of
persistent IPV on women’s use of contraception was greater than that of remittent or incident
IPV. Future research could continue to explore the importance of IPV duration in predicting
women’s use of contraception.
Implications for Practice
Understanding how IPV modifies women’s ability to adopt or to continue to use contraception
is central to informing evidence-based FP and HIV prevention interventions. Prior research in-
dicates that IPV is associated with HIV infection [10–12]. Given that this systematic review
found that women who report IPV are less likely to use condoms than women who do not re-
port IPV, HIV prevention interventions should consider addressing IPV.
The WHO recommends that providers ask women about exposure to IPV when assessing
conditions that may be caused or complicated by IPV [73] and FP providers should consider
asking specifically about reproductive coercion when screening for IPV [18,74]. The American
College of Obstetricians and Gynecologists offers specific guidance for providers to ask women
about their experience of reproductive coercion [74]. Recent clinical guidelines suggest that
health care providers caring for women who experience reproductive coercion should offer
contraceptive methods that are less susceptible to partner sabotage (e.g., IUD and implant)
while counseling women about IPV and safety planning strategies [75]. Ensuring that women
can access long-acting and permanent contraceptive methods could help women who experi-
ence IPV plan their families.
Conclusion
Pooling estimates from seven longitudinal studies that included 14,866 participants, women
who experienced IPV were less likely to use contraception than women who did not. The high
level of heterogeneity in the pooled estimate is typical of systematic reviews of non-randomized
studies and may be due to the inclusion of heterogeneous populations and exposure and out-
come measures or to residual confounding of effect measures from individual studies [26]. Fu-
ture research that includes longitudinal measures of IPV and women’s use of modern
contraceptive methods is needed to better understand the impact of IPV on women’s adoption
of contraception.
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